مقالے کی معلومات
جلد
شمارہ
مقالے کی قسم
زبان
تلخیص
The objective of present study was to estimate and compare the serum copper level in patients with benign prostatic hypertrophy and prostate carcinoma and their correlation with serum acid phosphatase. Prostatic acid phosphatase for Group A was 2.28 ± 0.99, for Group B 16.03 ± 5.89 and for Group c 46.43 ± 6.22 U/L, respectively. Highly significant P- value of 0.0001 was noted among all the 3 groups; A, B and C. Serum copper levels in Group A 106.88 ± 19.28, Group B 104.29 ± 17.40 and Group C 92.88 ± 11.28µg/L, respectively. P value between groups A vs B, A vs C and B vs C were noted as 0.052, 0.001 and 0.022, respectively. Serum copper was reduced in group B compared to A, but P value showed no significant difference (p=0.052). However, A vs C and B vs C showed statistically significant differences. The present study reports the raised prostatic acid phosphatase, and decreased serum copper levels in carcinoma of prostate gland indicating their diagnostic and prognostic significance.
Naheed Qadir, Jalil Qadir, Jamil Ahmed Siddiqui. (2019) SERUM COPPER LEVEL AS A PREDICTIVE MARKER IN PATIENTS OF MALIGNAT CANCEROUS PROSTATE AND BENIGN PROSTATIC HYPERPLASIA (BPH) ALONG WITH ITS CORRELATION TO SERUM ACID PHOSPHATASE, , Volume 16, Issue1.
-
Views
461 -
Downloads
42